Good Neighbor Pharmacy franchise research

Investment by format

Format-specific estimates only. Do not combine one format's minimum with another format's maximum.

Investment sourceFDD p.27 ↗

Franchise fees and ongoing costs

Franchise fee

$0 · Extracted Item 5 scalar range, not a universal minimum or maximum; formats, eligibility, discounts and waivers require original-filing review.

Royalty

$599 · Flat monthly fee (GNP Premier Fee), not a percentage of gross sales

Marketing contribution

Not captured

Technology fee

Not captured

Other fees

Claim Reconciliation Concierge Services $199/month (optional); Outcomes Premium Solution $49–$249/store/month (optional); EnlivenHealth Treat Solution $100–$185/store/month (optional)

Working capital (FDD Item 7)

Existing pharmacy: $40,000–$50,000; Start-up pharmacy: $120,000–$150,000 (3-month working capital covering phone, utilities, rent, security, trash removal, legal/accounting/professional services, office systems, and miscellaneous).

Fees sourceFDD p.23 ↗

Working capital is drawn from Item 7. The Investment source below locates the investment section, not an independently verified working-capital scalar.

Investment sourceFDD p.27 ↗

Franchise fee sourceFDD · page not captured ↗

Financial performance: Item 19

Item 19 captured

Yes

Metric / basis

Comparative performance statistics only (e.g., vaccinations administered, MTM services completed, enhanced-services dollars, five-star rebate payouts, front-end and private-label purchases, unsaleable returns recouped) comparing GNP Premier Pharmacies to non-Premier/Elevate-only pharmacies or industry benchmarks; no gross sales, revenue, or profit/EBITDA figures are disclosed.

Reporting period

Various 12-month and quarterly periods within FY2023–FY2025 (mostly September 2024–August 2025 or Q2 2025)

Sample

Varies by metric, ranging from approximately 776 to 2,624 participating stores per comparison

Reported average

Not captured

Reported median

Not captured

Owner income is not captured. Gross sales and EBITDA are not owner pay. Results depend on the disclosed metric, sample and period; consult the full filing.

Item 19 performance sourceFDD p.51 ↗

Unit growth: Item 20

Reporting year

2025

Scope

franchised outlets

Starting outlets

2294

Year-end outlets

2204

Net change

-90

Derivation

ending minus starting outlets

Openings

174

Terminations

264

Non-renewals

0

Other closures

0

Reacquisitions

0

Transfers

45

Transfers are not closures. Net change is ending minus starting outlets for the stated scope and year, or complete openings less terminations, non-renewals, other closures and reacquisitions. Missing inputs stay unknown.

Unit growth sourceFDD p.55 ↗

SBA loan history

Loan activity

9 approvals

Activity window

FY2021-FY2026 YTD; snapshot 2026-06-30

Median SBA loan

$820,000

Median loan window

FY2023-FY2026 YTD through 2026-06-30

Median loan sample

6 loans

Historical charge-off share

Suppressed: fewer than 10 seasoned loans

Cohort

7(a) FY2010-2019 approvals

Numerator / denominator

0 / 2

Formula

CHGOFF / (PIF + CHGOFF + EXEMPT) × 100

This is a historical loan-level share, not a franchise failure probability or location survival rate. Loan size is not total investment. Other loan statuses are excluded from the seasoned denominator. Activity combines 7(a) and 504 approvals, excluding canceled and not-funded records; this is not a rolling five-year count. FY2024-25 franchise tags are sparse after directory suspension; fewer tagged loans do not establish brand decline. Recent charge-off cohorts are immature.

SBA loans sourceSBA data · Jun 30, 2026 ↗

Median loan amounts are financing context, not startup cost. The median window is separate from the seasoned charge-off cohort.

Median SBA loan sourceSBA data · Jun 30, 2026 ↗

Questions before you invest

How much does Good Neighbor Pharmacy franchise cost?

existing pharmacy (conversion to GNP Premier): $43,797 to $556,405; start-up pharmacy: $278,797 to $575,205 These are format-specific estimates, not a guaranteed cash requirement. Franchise fee: $0 · Extracted Item 5 scalar range, not a universal minimum or maximum; formats, eligibility, discounts and waivers require original-filing review..

Investment sourceFDD p.27 ↗

Franchise fee sourceFDD · page not captured ↗

How much do Good Neighbor Pharmacy owners make?

Owner income is not captured. Gross sales and EBITDA are not owner pay. Item 19 metric: Comparative performance statistics only (e.g., vaccinations administered, MTM services completed, enhanced-services dollars, five-star rebate payouts, front-end and private-label purchases, unsaleable returns recouped) comparing GNP Premier Pharmacies to non-Premier/Elevate-only pharmacies or industry benchmarks; no gross sales, revenue, or profit/EBITDA figures are disclosed.. Sample: Varies by metric, ranging from approximately 776 to 2,624 participating stores per comparison. Period: Various 12-month and quarterly periods within FY2023–FY2025 (mostly September 2024–August 2025 or Q2 2025).

Item 19 performance sourceFDD p.51 ↗

What's the SBA charge-off rate for Good Neighbor Pharmacy?

Suppressed: fewer than 10 seasoned loans; numerator / denominator: 0 / 2. Historical 7(a) FY2010-2019 approvals; CHGOFF / (PIF + CHGOFF + EXEMPT) × 100, snapshot 2026-06-30. This is not a franchise failure probability. Median SBA loan: $820,000; window: FY2023-FY2026 YTD through 2026-06-30; sample: 6 loans. Median financing is not total investment.

SBA loans sourceSBA data · Jun 30, 2026 ↗

Median SBA loan sourceSBA data · Jun 30, 2026 ↗